Assessing the Effect of Selective Serotonin Reuptake Inhibitors in the Prevention of Post-Acute Sequelae of COVID-19.

Hythem Sidky David K Sahner Andrew T Girvin Nathan A HotalingSam G MichaelMichael G KurillaKen Gersing

Published in: medRxiv : the preprint server for health sciences (2022)

SSRIs may play a role in managing the long term disease burden of COVID-19. Future prospective studies are warranted to confirm these findings and evaluate potential mechanisms of action.

Keyphrases

coronavirus disease
sars cov
liver failure
respiratory syndrome coronavirus
drug induced
risk assessment
case control
hepatitis b virus